Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
Patients regain weight after stopping Eli Lilly's Zepbound, study says
01:53pm, Monday, 11'th Dec 2023
The data suggests that people have to stay on the weekly injection Zepbound if they want to maintain weight loss.
Eli Lilly Stock Falls on Data That Show Patients Who Stopped Zepbound Regained Weight
01:07pm, Monday, 11'th Dec 2023
A JAMA study shows that patients who stopped taking Zepbound after 36 weeks on the drug experienced a 14% weight regain over a year.
Midday Movers: Cigna Soars After Calling Off Humana Deal, Eli Lilly Falls Following Study
12:55pm, Monday, 11'th Dec 2023
U.S. equities were little changed at midday ahead of key inflation data due later in the week and the final Federal Reserve policy meeting of 2023. The Dow and S&P 500 were up slightly, while the Nasd
Here's what will happen if you stopped taking Eli Lilly's weight-loss drug
12:54pm, Monday, 11'th Dec 2023
Eli Lilly & Co (NYSE: LLY) is down nearly 4.0% today after a study indicated that weight-loss from Zepbound tends to reverse once the treatment is stopped. Patients regain weight if they stop taking Z
Eli Lilly obesity drug patients regained weight after ending treatment: study
12:21pm, Monday, 11'th Dec 2023
Individuals using Eli Lilly and Co (NYSE:LLY)'s obesity drug Zepbound (tirzepatide) regained weight after they stopped using the treatment, according to a study published Monday in the Journal of the
Patients on Eli Lilly's drug regain weight after stopping treatment - JAMA study
10:55am, Monday, 11'th Dec 2023
Patients on Eli Lilly's weight-loss drug trial substantially regained weight after stopping treatment, according to a study published in journal JAMA on Monday.
Future Trillion-Dollar Companies: 7 Stocks to Invest in Now
02:41pm, Sunday, 10'th Dec 2023
As 2024 unfolds, the spotlight falls on identifying the next trillion-dollar stocks. This elite club, currently consisting of six corporate giants at this time, symbolizes financial might, market infl
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
06:47pm, Friday, 08'th Dec 2023
The latest trading day saw Eli Lilly (LLY) settling at $598.05, representing a +1.66% change from its previous close.
Novo, Lilly rivals explore booming weight-loss drug market entry
09:58am, Friday, 08'th Dec 2023
Novo Nordisk and Eli Lilly have pulled ahead in the race for a slice of the weight-loss drugs market, expected to be worth $100 billion by the end of the decade, and rivals are looking to catch up thr
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
05:30am, Friday, 08'th Dec 2023
Novo Nordisk was first to market with its blockbuster weight loss treatment Wegovy. Doctors have prescribed Eli Lilly's diabetes treatment for weight loss.
Challenging the Magnificent 7: 3 Stocks on the Rise
05:15am, Friday, 08'th Dec 2023
While the benchmark S&P 500 index is up nearly 20% since the start of this year, the equal-weight version of the index is only up 6.2%. This is because the Magnificent 7 stocks, Alphabet (NASDAQ: GOO
Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund?
08:45am, Thursday, 07'th Dec 2023
Large-cap growth stocks have been major drivers of total stock market returns over the past century. This fact has driven a sharp rise in the popularity of large-cap growth ETFs over the past two deca
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
08:30am, Thursday, 07'th Dec 2023
Eli Lilly used to trade at no higher than 30 times earnings, but those days appear to be long gone. Investors are paying a big premium for the stock due to its highly effective weight-loss treatment.
'Ten-bagger' stocks are the 'holy grail': Strategist
12:00pm, Wednesday, 06'th Dec 2023
As Wall Street weighs whether markets can sustain November's rally, investors are spotting opportunities. eToro Global Markets Strategist Ben Laidler joined Yahoo Finance Live to analyze high-growth "
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
01:04pm, Tuesday, 05'th Dec 2023
Eli Lilly's drug serves as an alternative to rival obesity drugs such as Wegovy that are still facing supply issues.
